U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07930910) titled 'Dose-Escalation Stereotactic Ablative Radiotherapy for Ultra-Elderly Bladder Cancer' on Jan. 27.
Brief Summary: The goal of this ambispective cohort study is to evaluate the safety and palliative efficacy of a dose-escalated stereotactic ablative radiotherapy (SABR) protocol in ultra-elderly patients (age > 75) with medically inoperable bladder cancer. This study combines a retrospective analysis of early clinical cases with a prospective observation of subsequent patients treated under the same institutional protocol.
The main questions it aims to answer are:
1. What is the safety profile and durability of symptom control (specif...